Literature DB >> 28983716

Diagnostic and therapeutic evaluation of multiple choroidal granulomas in a patient with confirmed sarcoidosis using enhanced depth imaging optical coherence tomography.

Mami Ishihara1, Etsuko Shibuya2, Shin Tanaka2, Nobuhisa Mizuki2.   

Abstract

PURPOSE: Sarcoidosis is a major cause of granulomatous uveitis but rarely manifests as multiple choroidal granulomas. This report describes the use of enhanced depth imaging optical coherence tomography (EDI-OCT) to visualize changes occurring in multiple choroidal granulomas during treatment.
METHODS: The patient was a 36-year-old Japanese man with histopathologically confirmed sarcoidosis, who was examined using EDI-OCT and showed multiple yellowish-white subretinal lesions in the peripapillary region and the arcade of the right eye.
RESULTS: EDI-OCT revealed homogeneous hyporeflective choroidal lesions with choriocapillaris thinning, consistent with a diagnosis of choroidal granulomas. Subretinal fluid adjacent to one of the peripapillary choroidal lesions was also apparent. EDI-OCT during oral prednisolone administration revealed a decrease in lesion size at as early as 3 weeks and complete resolution of the lesions after 6 months of treatment. However, 2 months after prednisolone discontinuation, EDI-OCT revealed recurrence of choroidal granulomas in the peripapillary region and the arcade of the right eye. After injection of triamcinolone acetonide into the posterior sub-Tenon's capsule (sub-Tenon's injection), EDI-OCT demonstrated a reduction in granuloma lesion size within 3 months of the injection.
CONCLUSION: EDI-OCT allowed detailed morphologic visualization of the choroidal granulomas caused by sarcoidosis. This imaging technique was useful for monitoring changes in granuloma size in response to steroid administration and for early detection of recurrence. Injection of triamcinolone acetonide into the posterior sub-Tenon's capsule was as effective as oral prednisolone for the treatment of choroidal granulomas.

Entities:  

Keywords:  EDI-OCT; Multiple choroidal granulomas; Sarcoidosis; Sub-Tenon’s injection

Mesh:

Substances:

Year:  2017        PMID: 28983716     DOI: 10.1007/s10792-017-0720-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  19 in total

Review 1.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

2.  Intravitreal triamcinolone acetonide for choroidal granuloma in sarcoidosis.

Authors:  Wai-Man Chan; Etrian Lim; David T L Liu; Ricky W K Law; Dennis S C Lam
Journal:  Am J Ophthalmol       Date:  2005-06       Impact factor: 5.258

3.  Choroidal granulomas in systemic sarcoidosis.

Authors:  U R Desai; K A Tawansy; B C Joondeph; R M Schiffman
Journal:  Retina       Date:  2001       Impact factor: 4.256

Review 4.  Choroidal imaging using spectral-domain optical coherence tomography.

Authors:  Caio V Regatieri; Lauren Branchini; James G Fujimoto; Jay S Duker
Journal:  Retina       Date:  2012-05       Impact factor: 4.256

5.  LONGITUDINAL FOLLOW-UP OF CHOROIDAL GRANULOMAS USING ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY.

Authors:  Alessandro Invernizzi; Aniruddha Agarwal; Chiara Mapelli; Quan Dong Nguyen; Giovanni Staurenghi; Francesco Viola
Journal:  Retina       Date:  2017-01       Impact factor: 4.256

6.  Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.

Authors:  Yoshio Hirano; Takeshi Ito; Miho Nozaki; Tsutomu Yasukawa; Eiji Sakurai; Munenori Yoshida; Yuichiro Ogura
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

7.  Visualization of sarcoid choroidal granuloma by enhanced depth imaging optical coherence tomography.

Authors:  Olga Rostaqui; Giuseppe Querques; Patricia Haymann; Christine Fardeau; Gabriel Coscas; Eric H Souied
Journal:  Ocul Immunol Inflamm       Date:  2013-10-08       Impact factor: 3.070

8.  Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography.

Authors:  Alessandro Invernizzi; Chiara Mapelli; Francesco Viola; Mario Cigada; Luca Cimino; Roberto Ratiglia; Giovanni Staurenghi; Amod Gupta
Journal:  Retina       Date:  2015-03       Impact factor: 4.256

9.  Unilateral choroidal granulomas complicated by choroidal neovascular membrane treated successfully with intravitreal triamcinolone in a patient with sarcoidosis.

Authors:  Tasneem Khatib; Patrick W Hughes; Benjamin J L Burton
Journal:  BMJ Case Rep       Date:  2014-08-28

10.  International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).

Authors:  Carl P Herbort; Narsing A Rao; Manabu Mochizuki
Journal:  Ocul Immunol Inflamm       Date:  2009 May-Jun       Impact factor: 3.070

View more
  5 in total

Review 1.  Use of optical coherence tomography angiography in the uveitis clinic.

Authors:  Francesco Pichi; Steven Hay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-16       Impact factor: 3.535

Review 2.  Advances and potential new developments in imaging techniques for posterior uveitis. Part 1: noninvasive imaging methods.

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort; Alessandro Mantovani; Piergiorgio Neri; Moncef Khairallah
Journal:  Eye (Lond)       Date:  2020-07-16       Impact factor: 3.775

3.  A Case of Large Sarcoid Choroidal Granuloma Treated with Steroid Pulse Therapy.

Authors:  Takatoshi Kobayashi; Nanae Takai; Takaki Sato; Rei Tada; Eri Maruyama; Hiromi Shouda; Takako Okamoto; Kohichi Maruyama; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2020-03-11

4.  Sub-Tenon Injection of Triamcinolone Acetonide for Choroidal Mass in Sarcoidosis: A Case Report.

Authors:  Mihori Kita; Yu Kagitani; Sachiyo Hama; Atsushi Azumi
Journal:  Int Med Case Rep J       Date:  2021-01-29

Review 5.  Choroidal sarcoid granuloma: a case report and review of the literature.

Authors:  Dany G Hage; Charbel H Wahab; Wajiha J Kheir
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.